Market Place
Sourcing Support
MeMed BV Crosses 100K Tests for Host-Response Diagnostics
05 Jun 2025 //
BUSINESSWIRE
MeMed Expands Advisory Board For Sepsis & AMR Diagnostics
09 Jan 2025 //
BUSINESSWIRE
MeMed Further Solidifies Board of Directors Appointing Scott Garrett
09 Nov 2023 //
GLOBENEWSWIRE
MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman
06 Nov 2023 //
GLOBENEWSWIRE
MeMed awarded US BARDA contract to demonstrate clinical utility of MeMed test
24 Oct 2023 //
GLOBENEWSWIRE
MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result
19 Jul 2023 //
GLOBENEWSWIRE
MeMed: Nutex Health Announces Agreement with MeMed
25 May 2023 //
GLOBENEWSWIRE
Clinical data validate pioneering MeMed BV technology improves diagnosis
18 Apr 2023 //
GLOBENEWSWIRE
Tulsa ER & Hospital Adopts Trailblazing MeMed BV® Test
22 Dec 2022 //
GLOBENEWSWIRE
MeMed to Participate in Upcoming Conferences
29 Apr 2022 //
GLOBENEWSWIRE
MeMed to Host Webinar on Best Practice Clinical Use of MeMed BV®
21 Apr 2022 //
GLOBENEWSWIRE
MeMed to host integrated symposium, oral and poster presentation on MeMed BV
13 Apr 2022 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.